PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.330
https://www.valueinhealthjournal.com/article/S1098-3015(11)01892-4/fulltext
Title :
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)01892-4&doi=10.1016/j.jval.2011.08.330
First page :
A291
Section Title :
Mental Health
Open access? :
No
Section Order :
304